ASTH 📈 Astrana Health - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03763A2078

ASTH: Care Coordination, Medical Services, Healthcare Management

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California. Web URL: https://www.astranahealth.com

Additional Sources for ASTH Stock

ASTH Stock Overview

Market Cap in USD 1,827m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2000-01-13

ASTH Stock Ratings

Growth 5y 45.2%
Fundamental 25.8%
Dividend -
Rel. Strength Industry -230
Analysts 4.82/5
Fair Price Momentum 28.57 USD
Fair Price DCF 39.61 USD

ASTH Dividends

No Dividends Paid

ASTH Growth Ratios

Growth Correlation 3m -85.1%
Growth Correlation 12m 59.2%
Growth Correlation 5y 50.3%
CAGR 5y 12.33%
CAGR/Mean DD 5y 0.28
Sharpe Ratio 12m -0.12
Alpha -39.78
Beta 1.12
Volatility 53.55%
Current Volume 1050.5k
Average Volume 20d 315.5k
What is the price of ASTH stocks?
As of December 22, 2024, the stock is trading at USD 33.70 with a total of 1,050,500 shares traded.
Over the past week, the price has changed by -10.44%, over one month by -17.88%, over three months by -40.88% and over the past year by -6.70%.
Is Astrana Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Astrana Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.84 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASTH as of December 2024 is 28.57. This means that ASTH is currently overvalued and has a potential downside of -15.22%.
Is ASTH a buy, sell or hold?
Astrana Health has received a consensus analysts rating of 4.82. Therefor, it is recommend to buy ASTH.
  • Strong Buy: 10
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ASTH stock price target?
According to ValueRays Forecast Model, ASTH Astrana Health will be worth about 31.5 in December 2025. The stock is currently trading at 33.70. This means that the stock has a potential downside of -6.56%.
Issuer Forecast Upside
Wallstreet Target Price 67.1 99.1%
Analysts Target Price 49.7 47.4%
ValueRay Target Price 31.5 -6.6%